Sanofi partners with HHS to work on COVID-19 vaccine

Sanofi’s vaccine unit has united with the US Department of Health and Human Services (HHS) to develop a vaccine for the COVID-19 virus, which has so far killed more than 2,000 people worldwide.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Sanofi announces new vaccine project as Australia begins animal tests

2 April 2020 France’s Sanofi Pasteur and US biotechnology company Translate Bio have joined the race to develop a vaccine for SARS-CoV-2, the coronavirus behind COVID-19.

Big Pharma

Sanofi under fire over priority US access to COVID-19 vaccine

15 May 2020 Sanofi is facing criticism after CEO Paul Hudson said the US was likely to have priority access on any COVID-19 vaccine produced by the French pharmaceutical company.

Americas

HHS commits to IP transparency following watchdog’s criticism

26 November 2020 The US Department of Health and Human Services will reveal more information regarding its licensing of IP to private companies for drug development, it has confirmed in a letter to a congressional watchdog.

More on this story

Big Pharma

Sanofi announces new vaccine project as Australia begins animal tests

2 April 2020 France’s Sanofi Pasteur and US biotechnology company Translate Bio have joined the race to develop a vaccine for SARS-CoV-2, the coronavirus behind COVID-19.

Big Pharma

Sanofi under fire over priority US access to COVID-19 vaccine

15 May 2020 Sanofi is facing criticism after CEO Paul Hudson said the US was likely to have priority access on any COVID-19 vaccine produced by the French pharmaceutical company.

Americas

HHS commits to IP transparency following watchdog’s criticism

More on this story

Big Pharma

Sanofi announces new vaccine project as Australia begins animal tests

2 April 2020 France’s Sanofi Pasteur and US biotechnology company Translate Bio have joined the race to develop a vaccine for SARS-CoV-2, the coronavirus behind COVID-19.

Big Pharma

Sanofi under fire over priority US access to COVID-19 vaccine

15 May 2020 Sanofi is facing criticism after CEO Paul Hudson said the US was likely to have priority access on any COVID-19 vaccine produced by the French pharmaceutical company.

Americas

HHS commits to IP transparency following watchdog’s criticism